Integration of GARD Turkey national program with other non-communicable diseases plans in Turkey

Bulaşıcı olmayan hastalıkların önlenmesi ve kontrolü için, Dünya Sağlık Örgütü (DSÖ) tarafından bu hastalıklara ve risk faktörlerine yönelik koordine, kapsamlı ve kanıta dayalı girişim ve stratejilerin desteklenmesi amacıyla bir eylem planı hazırlanmıştır. Global Alliance against Chronic Respiratory Diseases (GARD) etkinlikleri de 40 ülkede sürmekte olup, 11 ülkede entegre eylem planı çalışmaları yapılmaktadır. GARD Türkiye projesinde de T.C. Sağlık Bakanlığı kronik hava yolu hastalıklarını önleme ve kontrol programını diğer bulaşıcı olmayan hastalıkların kontrol programlarıyla entegre etmektedir. Bu yazıda GARD Türkiye projesinin diğer ulusal kontrol programlarıyla entegrasyonu özetlenmiştir.

GARD Türkiye ulusal kontrol programının diğer bulaşıcı olmayan hastalıklar programlarıyla entegrasyonu

For the prevention and control of non-communicable diseases (NCD), an action plan on NCDs is intended to support coordinated, comprehensive and integrated implementation of strategies and evidence-based interventions across individual diseases and risk factors, especially at the national and regional levels by World Health Organization (WHO). The Global Alliance against Chronic Respiratory Diseases (GARD) is making every attempt to align with WHO s non-communicable diseases action plan. GARD activities have been commenced in over 40 countries and in 11 countries an integrated NCD action plan is being prepared or has already been initiated. This integrated approach of GARD has also targeted to GARD Turkey project. The Turkish Ministry of Health has decided to apply this national control program in conformity with other NCD action plans. This article is intended to summarize these integration efforts of GARD Turkey (the National Control Program on Chronic Airway Diseases) with other NCD national programs.

___

  • 1. World Health Organization. 2008-2013 Action Plan of the Global Strategy for the Prevention and Control of Noncommunicable Diseases. World Health Organization, Geneva, 2008.
  • 2. World Health Organization. Global Alliance against Chronic Respiratory Diseases Action Plan 2008-2013. World Health Organization, Geneva, 2008.
  • 3. WHO, Cardiovascular Diseases, Information Note N°317,; http://www.who.int/mediacentre/factsheets/fs317/ en/print.html (Access Date February 2007).
  • 4. Ministry of Health, Cardio Vascular Disease Control and Prevention Programme Strategic and Action Plan for the Risk Factors; Directorate General Primary Health Care Services; Ankara 2009.
  • 5. NCD net Working Group on Advocacy and Communications Background paper First NCDnet Global Forum World Health Organization (Geneva, 24 February 2010) www.who.int/ncdnet ©World Health Organization, 2010 www.who.int/about/copyright
  • 6. Global Surveillance, Prevention and Control of Chronic Respiratory Diseases: A Comprehensive Approach. ISBN 978 92 4 156346 8 (NLM Classification: WF 140) © World Health Organization 2007.
  • 7. Bousquet J, Dahl R, Khaltaev N. Global Alliance against Chronic Respiratory Diseases. Eur Respir J 2007; 29: 233-9.
  • 8. Turkish Ministry of Health Turkish Burden of Disease Study 2004, Ankara Turkey December 2006).
  • 9. Yorgancıoğlu A, Türktaş M, Kalaycı O, et al. The WHO global alliance against chronic respiratory diseases in Turkey (GARD Turkey). Tuberk Toraks 2009; 57: 439-52.
  • 10. www.saglik.gov.tr/GARD
Tüberküloz ve Toraks-Cover
  • ISSN: 0494-1373
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 1951
  • Yayıncı: Tuba Yıldırım
Sayıdaki Diğer Makaleler

Successful treatment of descending necrotizing mediastinitis with hemorrhagic complication

Rahim MAHMODLOU, Rahman ABBASIVASH

Evaluating the role of vitamin D receptor polymorphisms on susceptibility to tuberculosis among Iranian patients: a case-control study

Sayed Mehran MARASHIAN, Parissa FARNIA, Shima SEYF, Saber ANOOSHEH, Ali Akbar VELAYATI

Dysphonia and chest pain as presenting symptoms of pneumomediastinum

Gökhan M. MUTLU, Tomasz J. KUZNIAR, Tyler MORK

Determination of optimal drying period in wet to dry weight ratio measurement

Ali YEĞİNSU, Makbule ERGİN

Fizyolojik ölü boşluk ölçümünün ekstübasyon başarısını tahmin etmedeki rolü

Ezgi ÖZYILMAZ, Gül GÜRSEL, Müge AYDOĞDU

Kronik obstrüktif akciğer hastalığı olan olgularda serum grelin, IL-6 ve TNF-α düzeyleri

Nevin İLHAN, Ilgın KARACA, Teyfik TURGUT, Mehmet Hamdi MUZ, Yasemin DEVECİ, Figen DEVECİ

Prevalence of respiratory abnormalities and pneumoconiosis in dental laboratory technicians

Derya DOĞAN ÖZDEMİR, Nilüfer Tülin POLAT, Uğur DAL, Cesur GÜMÜŞ, Ali Kemal ÖZDEMİR, İbrahim AKKURT

Nadir görülen port kateter komplikasyonu

Nesrin KIRAL, Banu SALEPÇİ, Gülşen SARAÇ, Benan ÇAĞLAYAN, Tuğba YÜKSEL

Poland sendromu ve spontan pnömotoraks nadir bir birliktelik

Burçin ÇELİK

Etiological agents of community-acquired pneumonia in adult patients in Turkey; a multicentric, cross-sectional study

Kemalettin AYDIN, Rahmet ÇAYLAN, Özlem BAYRAKTAR, Nurgün SUCU, İftihar KÖKSAL, Gürdal YILMAZ, Funda ÖZTUNA, Tevfik ÖZLÜ, Yılmaz BÜLBÜL